You are here: Home / API / Antibiotics / Rifamycin Drugs / Rifamycin S (13553-79-2) C37H45NO12

Rifamycin S (13553-79-2) C37H45NO12

  • Chemical Name:Rifamycin S
  • CAS No.:13553-79-2
  • MF: C37H45NO12
  • MW:695.75
  • Specification: USP|EP|BP
  • Purity: 95%-99% or As customer requested
  • Product Categories:Antibiotics;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals
  • Test method: HPLC
Availability:

The rifamycins are a family of antibiotics produced by an actinomycete now classified as Amycolatopsis mediterranei. All the therapeutically useful rifamycins are semisynthetic derivatives of rifamycin B, a fermentation product that is poorly active, but easily produced and readily converted chemically into rifamycin S, from which most active derivatives are prepared. They all share the general structure.

Natural products like rifamycins, which are characterized by an aromatic ring spanned by an aliphatic bridge (ansa) are called ‘ansamycins’. To this class belong the streptovaricins and the tolypomycins (chemically and biologically similar to rifamycins) and geldanamycin and the maytansines, which have quite different, antiblastic, biological activities. Among the vast number of rifamycin derivatives investigated, rifampicin (rifampin) is by far the most important and most widely used. Various others, notably rifabutin, rifapentine and rifaximin, are also in use in various parts of the world. Rifamycin SV and rifamide are much less widely available.

Rifamycin EP Impurity B Chemical Structure

Rifamycin S            
Rifamycin S Chemical Properties   
Melting point  179-181°C (dec.)
alpha  D20 +476° (c = 0.1 in methanol)
Boiling point  700.89°C (rough estimate)
density  1.2387 (rough estimate)
refractive index  1.6630 (estimate)
form  neat
pka 3.85±0.70(Predicted)
λmax 390nm(MeOH)(lit.)
Merck  14,8217
InChIKey BTVYFIMKUHNOBZ-ODRIEIDWSA-N

Rifamycin S Usage And Synthesis


Uses Semi-synthetic antibiotic.
Clinical Use The rifamycins are a group of chemically related antibioticsobtained by fermentation from cultures of Streptomycesmediterranei. They belong to a class of antibiotics called theansamycins that contain a macrocyclic ring bridged acrosstwo nonadjacent positions of an aromatic nucleus. The termansa means “handle,” describing well the topography of thestructure. The rifamycins and many of their semisynthetic derivativeshave a broad spectrum of antimicrobial activity.They are most notably active against Gram-positive bacteriaand M. tuberculosis. However, they are also active againstsome Gram-negative bacteria and many viruses. Rifampin, asemisynthetic derivative of rifamycin B, was released as anantitubercular agent in the United States in 1971. A secondsemisynthetic derivative, rifabutin, was approved in 1992 forthe treatment of atypical mycobacterial infections.
The chemistry of rifamycins and other ansamycins hasbeen reviewed. All of the rifamycins (A, B, C, D, and E) arebiologically active. Some of the semisynthetic derivatives ofrifamycin B are the most potent known inhibitors of DNAdirectedRNA polymerase in bacteria, and their action isbactericidal. They have no activity against the mammalianenzyme. The mechanism of action of rifamycins as inhibitorsof viral replication appears to differ from that for their bactericidalaction. Their net effect is to inhibit the formation of thevirus particle, apparently by preventing a specific polypeptideconversion.77 Rifamycins bind to the β subunit of bacterialDNA-dependent RNA polymerases to prevent chain initiation.78 Bacterial resistance to rifampin has been associatedwith mutations leading to amino acid substitution in the subunit.78 A high level of cross-resistance between variousrifamycins has been observed.

MSDS: MSDS available

COA: COA can be available if you send us inquiry.

Email us at: info@maxmedchem.com for more details.

packagingpacking&shipping

LEAVE MESSAGE

Active Pharmaceutical Ingredients (APIs)& Pharma intermediates Supplier

MAPS

ABOUT US

Maxmedchem Corporation, was founded in 2004 and is the one of top manufacturers of Active Pharmaceutical Ingredients (APIs), and intermediates.

CONTACT US

Add : 1901 S.Lynx Place, Ontario, CA 91761
Phone : +16263716327
Copyright © 2021 MAXMEDCHEM Co. Ltd. All rights reserved. | Sitemap